Links from this page to related variants, conditions, drugs and topics are not included for automated readers. Those connections are the Gene Knowledge Graph and are licensed as data: https://www.mygenelog.com/license

Standard

Triglycerides to Total Lipids in Very Large HDL percentage

SERPINA1 · rs709932

Strength of the evidence

2 / 4

Its strongest genetic-study result is p = 10−36, with 16 associations in the GWAS Catalog.

How this is scored

4: ClinVar disease-causing, reviewed by an expert panel or a guideline (3–4 stars). 3: ClinVar, several labs agreeing (2 stars), or a genetic study at p ≤ 10−50. 2: ClinVar from one lab (1 star), or p ≤ 10−20. 1: ClinVar submitted without criteria (0 stars), or genome-wide significance (p ≤ 5×10−8). The higher of the two counts. It says how solid the evidence is, not whether it matters for a particular person.

What the study found

Who was studied 434,646 British ancestry individuals, 8,796 British Central/South Asian individuals, 6,573 British African individuals.

The effect Each copy of the T allele shifted the measure 0.02 % lower (95% confidence interval 0.02-0.02); p = 2 × 10−11.

Where it sits Chromosome 14, band 14q32.13 — a missense change in SERPINA1.

What ClinVar records

Classification Benign/Likely benign for PI M4, PI M2, Alpha-1-antitrypsin deficiency, Inborn genetic diseases; criteria provided, multiple submitters, no conflicts (2 of 4 stars, 16 submitters), last evaluated 2026-02-04. ClinVar record 17957 NM_001127701.1(SERPINA1):c.374G>A (p.Arg125His)

Change history MyGeneLog™ keeps a copy of every weekly release from 2026-10-19 and compares them. This position's classification has not changed since.

What this is ClinVar's aggregate record for this position (as of its 2026-11-01 release), not a result about you. A classification describes the variant against the condition named, as laboratories submitted it. Whether a person carries this variant, and what that would mean for them, is a question for a clinical test and a genetic counsellor.

How common each version is

CT
Korean KRGDB
C 81.5% · T 18.6%
Korean Korea4K
C 81.8% · T 18.2%
Japanese ToMMo
C 75.8% · T 24.2%
Vietnamese
C 72.3% · T 27.7%
World gnomAD
C 87.4% · T 12.6%
World 1000 Genomes
C 84.0% · T 16.1%
World TOPMed
C 88.3% · T 11.7%

By ancestry gnomAD

East Asian
C 78.0% · T 22.1%
European (non-Finnish)
C 83.9% · T 16.1%
African / African American
C 96.1% · T 3.9%
South Asian
C 72.0% · T 28.0%
Admixed American (Latino)
C 87.9% · T 12.1%
Middle Eastern
C 77.2% · T 22.8%
Finnish
C 87.9% · T 12.1%
Ashkenazi Jewish
C 83.8% · T 16.2%

The share of all copies of this position that are each version. Source: the population studies published in dbSNP (US NCBI); each row names its study. The ancestry rows are gnomAD's own groups (via Ensembl), as the survey defines them, not races.

What each result means

C/C No copy of the version the research linked to Triglycerides to Total Lipids in Very Large HDL percentage. This is the starting point the study compared everyone against.
C/T One copy of the version the research linked to Triglycerides to Total Lipids in Very Large HDL percentage. That is a smaller link than two copies.
T/T Two copies of the version the research linked to Triglycerides to Total Lipids in Very Large HDL percentage. That is the strongest link of the three results. A link in a study is not a diagnosis.
Source

Quoting this page

Licensed CC BY-NC 4.0: free to read, share and adapt for non-commercial use, naming MyGeneLog™ and linking the exact page. Commercial use, including training or serving a commercial AI system, needs a licence — https://www.mygenelog.com/license

Triglycerides to Total Lipids in Very Large HDL percentage (rs709932). MyGeneLog™. https://www.mygenelog.com/variants/rs709932

← See all variants